Appraisal of Triglyceride-Related Markers as Early Predictors of Metabolic Outcomes in the PREVIEW Lifestyle Intervention: A Controlled Post-hoc Trial

Santiago Navas‐Carretero, Rodrigo San-Cristóbal, Pia Siig Vestentoft, Jennie Brand‐Miller, Elli Jalo, Margriet S. Westerterp‐Plantenga, Elizabeth J. Simpson, Teodora Handjieva‐Darlenska, Gareth Stratton, Maija Huttunen‐Lenz, Tony Lam, Roslyn Muirhead, Sally D. Poppitt, Kirsi H. Pietiläinen, Tanja C. Adam, Moira A. Taylor, Svetoslav Handjiev, Melitta A. McNarry, Sylvia Hansen, Shannon Brodie, Marta P. Silvestre, Ian Macdonald, Nadka Boyadjieva, Kelly A. Mackintosh, Wolfgang Schlicht, Amy Liu, Thomas Meinert Larsen, Mikael Fogelholm, Anne Raben, J. Alfredo MartínézFrontiers in Nutrition 2021 · DOI

Abstract

Individuals with pre-diabetes benefit from weight loss and glycemic control, yet responses to lifestyle interventions vary significantly. This post-hoc analysis of the PREVIEW study (n=899) evaluated whether the triglyceride glucose (TyG) index and the TyG-waist phenotype could predict individual responses to type-2 diabetes (T2D) prevention programs. Results showed that higher baseline TyG values were associated with greater reductions in body weight, fasting glucose, and triglycerides. Furthermore, a high TyG-waist phenotype predicted superior triglyceride responses, particularly in individuals performing moderate-intensity physical activity. These simple, inexpensive markers may facilitate a more personalized approach to metabolic management.

Introduction

Lifestyle interventions involving diet and exercise are fundamental to preventing Type 2 Diabetes (T2D). However, clinical practice often reveals a wide range of individual responses; some patients achieve significant metabolic improvements while others see minimal change despite adherence. To advance "precision nutrition," clinicians require accessible tools to identify which individuals will benefit most from specific strategies. While the euglycemic-hyperinsulinemic clamp is the gold standard for measuring insulin resistance, its complexity makes it unsuitable for routine use. This study investigates whether surrogate markers derived from standard blood work—the TyG index and the TyG-waist phenotype—can serve as effective predictors of intervention success.

Methods

This research is a secondary analysis of the PREVIEW trial, a multi-center randomized controlled trial involving 899 individuals with pre-diabetes across eight countries. The intervention followed a two-stage design:

  1. Initial Weight Loss: A 2-month phase using a low-energy diet to achieve at least 8% weight loss.
  2. Maintenance Phase: A 34-month phase comparing two dietary protein levels (High vs. Moderate) and two physical activity intensities (High vs. Moderate) in a 2x2 factorial design.

The primary markers analyzed were:

  • TyG Index: Calculated as $Ln [Triglycerides (mg/dl) * Fasting\ Plasma\ Glucose (mg/dl) / 2]$.
  • TyG-waist Phenotype: Calculated as $TyG\ index * Waist\ Circumference (cm)$.

Key Results

The study found that baseline metabolic status significantly influenced the degree of improvement. Individuals with the highest baseline TyG and TyG-waist scores—indicating greater initial insulin resistance—experienced the most substantial metabolic benefits.

Specifically, a higher baseline TyG index was strongly associated ($p < 0.001$) with greater reductions in body weight, BMI, and fasting glucose across all four intervention groups. This suggests that those with the most "room for improvement" are highly responsive to structured lifestyle changes.

Figure 6: Linear regression analysis showing the association between baseline TyG index and changes in BMI (A), waist circumference (B), fasting glucose (C), and TyG index (D) across the four intervention groups.

Furthermore, the TyG-waist phenotype proved to be a valuable predictor for lipid management. High baseline TyG-waist scores predicted better triglyceride (TG) responses. Interestingly, participants in the moderate-intensity physical activity (MI-PA) group showed significantly better TG reductions ($p = 0.004$) compared to those in the high-intensity group, suggesting that for certain metabolic phenotypes, moderate exercise may be more effective for lipid control.

Discussion

The findings highlight the potential of TyG-related indices as scalable clinical tools. These markers performed comparably to or better than more complex measures like HOMA-IR, yet only require a standard lipid panel and a waist measurement.

The observation that moderate-intensity exercise was more effective for lipid management in high-risk phenotypes challenges the conventional "more is better" approach to exercise intensity. This insight is crucial for tailoring physical activity recommendations to individual metabolic profiles.

Limitations and Future Work

The study's post-hoc nature means it was not originally designed to test these markers as primary endpoints. Additionally, the analysis focused on "completers," which may introduce selection bias. Prospective trials are necessary to confirm these indices' utility in clinical decision-making. Future research should also explore the underlying mechanisms that make moderate-intensity exercise particularly effective for lipid management in insulin-resistant individuals.

Conclusion

The TyG index and TyG-waist phenotype are simple, cost-effective markers that can predict individual responses to T2D prevention programs. By identifying those most likely to benefit from specific dietary or exercise interventions, these tools support the move toward personalized metabolic health strategies.

Summary updated

Abstract

<b>Background:</b> Individuals with pre-diabetes are commonly overweight and benefit from dietary and physical activity strategies aimed at decreasing body weight and hyperglycemia. Early insulin resistance can be estimated <i>via</i> the triglyceride glucose index {TyG = Ln [TG (mg/dl) × fasting plasma glucose (FPG) (mg/dl)/2]} and the hypertriglyceridemic-high waist phenotype (TyG-waist), based on TyG x waist circumference (WC) measurements. Both indices may be useful for implementing personalized metabolic management. In this secondary analysis of a randomized controlled trial (RCT), we aimed to determine whether the differences in baseline TyG values and TyG-waist phenotype predicted individual responses to type-2 diabetes (T2D) prevention programs. <b>Methods:</b> The present <i>post-hoc</i> analyses were conducted within the Prevention of Diabetes through Lifestyle intervention and population studies in Europe and around the world (PREVIEW) study completers (<i>n</i> = 899), a multi-center RCT conducted in eight countries (NCT01777893). The study aimed to reduce the incidence of T2D in a population with pre-diabetes during a 3-year randomized intervention with two sequential phases. The first phase was a 2-month weight loss intervention to achieve ≥8% weight loss. The second phase was a 34-month weight loss maintenance intervention with two diets providing different amounts of protein and different glycemic indices, and two physical activity programs with different exercise intensities in a 2 x 2 factorial design. On investigation days, we assessed anthropometrics, glucose/lipid metabolism markers, and diet and exercise questionnaires under standardized procedures. <b>Results:</b> Diabetes-related markers improved during all four lifestyle interventions. Higher baseline TyG index (<i>p</i> < 0.001) was associated with greater reductions in body weight, fasting glucose, and triglyceride (TG), while a high TyG-waist phenotype predicted better TG responses, particularly in those randomized to physical activity (PA) of moderate intensity. <b>Conclusions:</b> Two novel indices of insulin resistance (TyG and TyG-waist) may allow for a more personalized approach to avoiding progression to T2D. <b>Clinical Trial Registration:</b> https://clinicaltrials.gov/ct2/show/NCT01777893 reference, identifier: NCT01777893.
BibTeX
@inproceedings{navascarretero2021appraisal,
  author = {Santiago Navas‐Carretero and Rodrigo San-Cristóbal and Pia Siig Vestentoft and Jennie Brand‐Miller and Elli Jalo and Margriet S. Westerterp‐Plantenga and Elizabeth J. Simpson and Teodora Handjieva‐Darlenska and Gareth Stratton and Maija Huttunen‐Lenz and Tony Lam and Roslyn Muirhead and Sally D. Poppitt and Kirsi H. Pietiläinen and Tanja C. Adam and Moira A. Taylor and Svetoslav Handjiev and Melitta A. McNarry and Sylvia Hansen and Shannon Brodie and Marta P. Silvestre and Ian Macdonald and Nadka Boyadjieva and Kelly A. Mackintosh and Wolfgang Schlicht and Amy Liu and Thomas Meinert Larsen and Mikael Fogelholm and Anne Raben and J. Alfredo Martínéz},
  title = {{Appraisal of Triglyceride-Related Markers as Early Predictors of Metabolic Outcomes in the PREVIEW Lifestyle Intervention: A Controlled Post-hoc Trial}},
  booktitle = {Frontiers in Nutrition},
  year = {2021},
  doi = {10.3389/fnut.2021.733697},
}
Figure